Eton Pharmaceuticals (NASDAQ:ETON) specializes in developing, acquiring, and marketing a broad range of pharmaceutical products with a focus on rare diseases and hospital-based conditions. The company aims to bring innovative treatments to market that can significantly improve patients' lives, particularly in areas where there are few or no existing therapeutic options. With a commitment to excellence in pharmaceutical development, Eton Pharmaceuticals continuously seeks new projects and opportunities to expand its portfolio of products. The goal is to address unmet medical needs and offer better health solutions through its specialized and effective pharmaceutical offerings.